Home » Authors » Mark Lawson

Articles by Mark Lawson

Australian Firm Defends Fees For Access To Noncoding DNA

July 16, 2003

BresaGen Sues Research Group After Cancer Data Not Duplicated

July 9, 2003

BresaGen Sues Research Group After Cancer Data Not Duplicated

July 9, 2003

Amrad, Merck Enter Alliance Apparently Focused On Asthma

July 2, 2003

Amrad, Merck Enter Alliance Apparently Focused On Asthma

July 2, 2003

SIRTeX Shareholders Block Cephalon Acquisition Attempt

June 4, 2003

SIRTeX Shareholders Block Cephalon Acquisition Attempt

June 4, 2003

Australian Groups In Dispute Over Patent Rights To RNAi

March 5, 2003

Australian Groups In Dispute Over Patent Rights To RNAi

March 5, 2003

Peptech Suffers On Uncertainty Of Royalties For TNF Product

Feb. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.